Among these, fructose-1,6-bisphosphatase 2 (FBP2), a key gluconeogenic enzyme, has been shown to be silenced in many subtypes of soft tissue sarcomas (STS), according to a study by Huangyang et al. [7]. This evidence concerns the gene FBP2 and telomere syndrome.